Dr Jia Ruan at ASH 2014: Phase II study of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma (Part 1 of 2)

At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Jia Ruan (Weill Cornell Medical College, New York, NY) discusses a phase II study of the biologic doublet of lenalidomide plus ritux... Author: EMJ Added: 04/13/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts